Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China
(Open Access)
机构:[1]Cancer Institute,the Fourth Hospital of Hebei Medical University/the Tumor Hospital of Hebei Province,Shijia zhuang,Hebei 050000,P.R.China临床科室河北省肿瘤研究所河北医科大学第四医院[2]Zhejiang Cancer Center,Hangzhou,Zhejiang 310000,P.R.China浙江省肿瘤医院[3]Henan Cancer Hospital,Zhengzhou,Henan 450000,P.R.China河南省肿瘤医院[4]Beijing Cancer Hospital,Beijing 100021,P.R.China[5]Hubei Cancer Hospital,Wuhan,Hubei 430000,P.R.China[6]Zhongshan Cancer Hospital,Zhongshan,Guangdong 528400,P.R.China[7]National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Science&Peking Union Medical College,Beijing100021,P.R.China
第一作者机构:[1]Cancer Institute,the Fourth Hospital of Hebei Medical University/the Tumor Hospital of Hebei Province,Shijia zhuang,Hebei 050000,P.R.China
通讯作者:
通讯机构:[7]National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Science&Peking Union Medical College,Beijing100021,P.R.China[*1]National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Science&Peking Union Medical College,Beijing 100021, P. R. China.
推荐引用方式(GB/T 7714):
Yutong He,Di Liang,Lingbin Du,et al.Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China
(Open Access)[J].CANCER COMMUNICATIONS.2020,40(10):531-544.doi:10.1002/cac2.12087.
APA:
Yutong He,Di Liang,Lingbin Du,Tiantian Guo,Yanyu Liu...&Wanqing Chen.(2020).Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China
(Open Access).CANCER COMMUNICATIONS,40,(10)
MLA:
Yutong He,et al."Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China
(Open Access)".CANCER COMMUNICATIONS 40..10(2020):531-544